MP ‐AzeFlu provides rapid and effective allergic rhinitis control: results of a non‐interventional study in Denmark

ConclusionMP ‐AzeFlu provided effective, rapid, and sustained symptom control in a real‐life setting among patients from Denmark. These results align with EU and ARIA objectives and support the effectiveness of MP‐AzeFlu for the treatment of AR in real life.

Source: International Forum of Allergy and Rhinology - March 27, 2019 Category: Allergy & Immunology Authors: Peter A. Haahr, Claus Jacobsen, Maria E. Christensen Tags: ORIGINAL ARTICLE Source Type: research